The University of Chicago Header Logo

Connection

Kenneth S. Cohen to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications Kenneth S. Cohen has written about TOR Serine-Threonine Kinases.
Kenneth S. Cohen
Connection Strength
0.190
TOR Serine-Threonine Kinases
  1. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model. Clin Cancer Res. 2013 Sep 01; 19(17):4553-8.
    View in: PubMed
    Score: 0.101
  2. Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas. Haematologica. 2022 07 01; 107(7):1608-1618.
    View in: PubMed
    Score: 0.047
  3. A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low-grade glioma. Pediatr Blood Cancer. 2021 02; 68(2):e28787.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.